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HEPATIC allograft rejection results from the trans-plant recipient’s immune response against allogeneic
antigens of the donor liver.1 Acute cellular rejection (ACR)
is common after orthotopic liver transplantation (OLT),
usually occuring in the first 3 weeks after transplantation2
and is initiated by alloactivation of recipient T cells through
both direct and indirect pathways.1 The control of ACR is
one of the most important aspect in the treatment of
posttransplant recipients because it determines prognosis.3
It is generally accepted that helper T lymphocytes play a
central role in the triggering of allograft rejection,4 espe-
cially by the secretion of cytokines, that provide help for the
activation, proliferation, and differentiation of other lym-
phocytes.1 After activation, helper T lymphocytes are po-
larized into two major subsets, Th1 and Th2, based on their
cytokine production.5–7 Similarly, cytotoxic T (Tc) lympho-
cytes may differentiate into Tc1 and Tc2 populations with
cytokine profile analogous to those seen in Th subpopula-
tions.8
Th1 cells produce interleukin-2 (IL-2) and interferon-g
(IFNg) and promote immunopathologic functions by me-
diating delayed-type hypersensitivity (DTH),1 and fre-
quently this type of immune activation is usually manifested
during allograft rejection.6 Th2 cells produce IL-4, IL-5 and
IL-10, among others,5 provide B cell help, and could inhibit
Th1 proliferation and cytokine secretion. Th2 cells may
modulate acute rejection and the development of allograft
tolerance.9 Also Th2 cytokine transcripts correlate with
milder rejection episodes.10 These findings led to the hy-
pothesis that immune deviation from a Th1 to a Th2
cytokine profile could play a crucial role in long-term graft
survival.6
Flow cytometry emerged as the premier technique for the
enumeration of cytokine producing cells, allowing the si-
multaneous detection of at least two cytokines at single cell
level.
The aim of this study was to quantify, by flow cytometry,
the frequency of IFNg, IL-4, and IL-10 producing T lym-
phocytes in the peripheral blood of patients undergoing
OLT and correlate the results with the presence or absence
of ACR. For this purpose, were studied patients at pre-
transplantation and twice a week in the first month after
OLT.
MATERIAL AND METHODS
Twenty-two patients were studied immediately before OLT and
two times a week in the first month after transplant. Five of these
patients developed an ACR, confirmed by biopsy, between day 11
and 14 after transplant.
After density gradient separation of mononuclear cells, 2 3 106
cells were incubated in 24 wells plate (2 replicates), with 2 mL
RPMI-1640 (Gibco; Paisley, Scotland) containing 10% of human
AB serum (Sigma, Germany), 50 ng/mL of phorbol 12-Myristate
13-Acetate (PMA; Sigma, Germany), 1 mmol of ionomycin (Boehr-
inger Mannheim, Germany) and 1.3 mL of brefeldin A (Golgi
plug—Pharmingen, San Diego, Calif) during four hours at 37°C in
a humidified incubator in 5% CO2 in air. Cultures in the absence of
brefeldin A and/or PMA 1 ionomycin were also done to be used as
negative controls.
Monoclonal antibodies (MoAbs), from R&D Systems (Abing-
don, UK), were used anti-human cytokine MoAbs: anti-IFNg-
FITC/clone #25723.11 and IL-4-PE/clone #3007.11. Anti-human
IL-10-PE/clone JES3-19F1 was obtained from Pharmingen. MoAb
anti-human CD3 (PECy5 conjugated-TC) was obtained from
Caltag laboratories (South San Francisco, Calif).
After cell surface staining of 1 3 106 mononuclear cells with 10
ml of anti-CD3-TC during 10 minutes at room temperature in the
dark and wash twice with PBS, the intracellular cytokine staining
was performed as described by Prussin and Metcalf. Thoroughly
resuspended cells were previously fixed and permeabilized with 250
ml of cytofix/cytoperm (Pharmingen) solution during 20 minutes at
4°C in the dark. Then, cells were washed twice with 13 Perm/wash
solution (Pharmingen’s cytostain Kit 103 solution—diluted to 13
in water) and pelleted. After an optimal concentration of MoAbs,
specific for appropriate cytokines and isotype controls has been
added, cells were incubated at 4°C for 30 minutes in the dark. Cells
were washed twice with 1 mL of perm/wash solution and resus-
pended in 0.7 mL OS PBS (Gibco; Paisley, Scotland)-1%
paraformaldehyd (Merk Darnstadt, Germany).
Samples were acquired on the Epics XL (Coulter, Hialeah, Fla,
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USA) using XL-II software. The number of events acquired for
each sample was 15.000 on a CD31 gate, after a first gate was
performed on viable cells.
Statistical analysis were carried out using standard t test per-
formed by Macintosh (Cupertino, Calif) computer program Stat-
view 5121 (Abacus, Berkeley, Calif).
RESULTS
Immediately before OLT were observed in the group that
developed an ACR between day 11 and 14, a higher
frequency of IFNg producing T Ly (Fig 1) and a lower
frequency of IL-4 and IL-10 producing T Ly, which results
in a higher ratio Th1/Th2 in the group with ACR (Table 1).
After OLT were found in both groups (between day 1
and 3), a significantly decrease in the frequency of IFNg
producing T Ly, which was more evident in the group with
ACR (Fig 1). In the group without ACR, between day 4 and
day 7, this frequency returns to the level obtained before
transplantation and remains without any significant change
during the first month after transplantation (Fig 1).
In the group with ACR were observed, after day 3, a
significant increase in frequency of IFNg producing T Ly,
reaching the maximum value around day 10 (before the
occurence of rejection episode between day 11 and 14) (Fig
1).
Although the observed variability of results obtained for
the frequency of IL-10 and IL-4 producing T Ly, the group
with ACR seems to have, after OLT, higher frequencies of
IL-10 producing T Ly, presenting a maximum value be-
tween day 11 and 14 (Fig 2). Concerning the frequency of
IL-4 producing T Ly, after OLT, we didn’t find any signif-
icant statistical difference between the two studied groups
(Fig 3).
DISCUSSION
Acute rejection of allografts remains a significant problem
in clinical transplantation, decreasing the function and
survival of transplanted organs.11 The severity of the rejec-
tion process may partially depend on the presence of
environmentally primed T cells in the recipient that cross-
react with donor histocompatibility antigens.12
Th1 type cytokines have been correlated with acute graft
rejection severity as well as a kind of selective recruitment
of Th1 cells into sites of DTH reactions,1 probably due to
the expression of selectin ligands in cell surface. On con-
Fig 1. Profile of the frequency (%) of IFNg-producing T lym-
phocytes immediately before and after OLT in the group with
acute cellular rejection (ACR) between days 11 and 14 and in the
group without rejection episodes (NACR).  Statistically signifi-
cant value (P , .05).
Table 1. Frequency (%) of Cytokine-Producing T-Ly
IFNg IL-4 IL-10 Th1/Th2
NACR (n 5 17) 7.1 6 6.6 1.7 6 2.7 1.0 6 0.7 11.1 6 10.6
ACR (n 5 5) 15.0 6 11.1* 0.7 6 0.2 0.4 6 0.2* 27.6 6 31.6*
*Statistically significant value (P , .05).
NACR, no acute cellular rejection.
ACR, acute cellular rejection.
Frequencies obtained immediately before OLT. The results of Th1/Th2 were
calculated by the ratio between IFNg and IL-4 values.
Fig 2. Profile of the frequency (%) of IL-10 producing T
lymphocytes immediately before and after OLT in the group with
acute cellular rejection (ACR) between days 11 and 14 and in the
group without rejection episodes (NACR).  Statistically signifi-
cant value (P , .05).
Fig 3. Profile of the frequency (%) of IL-4 producing T lympho-
cytes immediately before and after OLT in the group with acute
cellular rejection (ACR) between days 11 and 14 and in the group
without rejection episodes (NACR).
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trary, Th2 type cytokines have been correlated to a certain
tolerance induction and a promoting graft survival.13
The higher frequency of IFNg producing T Ly and of
ratio Th1/Th2 observed immediately before OLT (Table 1)
(Fig 1), in the group with ACR, seems to be related with a
higher risk of posttransplantation rejection episodes and
could be a good prognosis factor of liver transplantation.
These findings are in agreement with others studies in renal
transplantation.12
In the first days after OLT was observed, a significant
decrease of frequency of IFNg and IL-4 producing T Ly, in
both groups (Fig 1 and 3), probably due to the immuno-
suppression treatment.5 The frequency of IL-10 producing
T Ly seems not be affected (Fig 2) since the transcription
factor NFAT, inhibited by immunosuppressors, is not in-
volved in IL-10 synthesis.5
Before and during the acute rejection episode, we ob-
served a significant increase in the frequency of IFNg-
producing T Ly (Fig 1), pointing to a preferential activation,
differentiation, and recruitment of Th1 cells, which are in
agreement with the results obtained in other solid organ
transplantation.10,14–16 This increase in frequency of IFNg-
producing T Ly, before and during ACR, could be an useful
marker of prediction of rejection episodes in liver trans-
plantation.
Although the low numbers of IL-10 and IL-4 producing T
Ly obtained in both studied groups, the group with ACR
seems to present higher frequencies of IL-10 producing
cells, especially during the rejection episode (day 11 to 14)
(Fig 2). A slight increase of IL-4 producing T Ly was also
observed in this group before and during the rejection
episodes (Fig 3). These small differences observed could be
due to a differentiation of lower proportion of Ly to Th2
subset after activation of Th0 Ly. Nevertheless, higher
levels of IL-1015 and IL-10 high producer genotype recipi-
ents13 have been correlated with graft rejection.
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